Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 230

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Criteria for the translation of radiomics into clinically useful tests

Open access
Huang, Erich P., O’Connor, James P. B., McShane, Lisa M., Giger, Maryellen L., Lambin, Philippe, Kinahan, Paul E., Siegel, Eliot L., Shankar, Lalitha K. · 2023 · Nature Reviews Clinical Oncology

Abstract

Despite tens of thousands of radiomic studies, the number of settings in which radiomics is used to guide clinical decision-making is limited, in part owing to a lack of standardization of the radiomic measurement extraction processes and the lack of evidence demonstrating adequate clinical validity and utility. Processes to acquire and process source images and extract radiomic measurements should be established and harmonized. A radiomic model should be tested on external data not used for its development or, if no such dataset is available, tested using proper internal validation techniques. Model outputs should be shown to guide disease management decisions in a way that leads to a favourable risk–benefit balance for patients. Clinical performance should be assessed periodically in its intended clinical setting (task and population) after model lockdown. A list of 16 criteria for the optimal development of a radiomic test has been compiled herein and should hopefully guide the implementation of future radiomic analyses. Despite a considerable increase in research output over the past decades, the translation of radiomic research into clinically useful tests has been limited. In this Review, the authors provide 16 key criteria to guide the clinical translation of radiomics with the hope of accelerating the use of this technology to improve patient outcomes. Computer-extracted tumour characteristics have been incorporated into medical imaging computer-aided diagnosis (CAD) algorithms for decades. With the advent of radiomics, an extension of CAD involving high-throughput computer-extracted quantitative characterization of healthy or pathological structures and processes as captured by medical imaging, interest in such computer-extracted measurements has increased substantially. However, despite the thousands of radiomic studies, the number of settings in which radiomics has been successfully translated into a clinically useful tool or has obtained FDA clearance is comparatively small. This relative dearth might be attributable to factors such as the varying imaging and radiomic feature extraction protocols used from study to study, the numerous potential pitfalls in the analysis of radiomic data, and the lack of studies showing that acting upon a radiomic-based tool leads to a favourable benefit–risk balance for the patient. Several guidelines on specific aspects of radiomic data acquisition and analysis are already available, although a similar roadmap for the overall process of translating radiomics into tools that can be used in clinical care is needed. Herein, we provide 16 criteria for the effective execution of this process in the hopes that they will guide the development of more clinically useful radiomic tests in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41571-022-00707-0

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 230

Metadata

Authors
Huang, E. P., O’Connor, J. P. B., McShane, L. M., Giger, M. L., Lambin, P., Kinahan, P. E., Siegel, E. L., & Shankar, L. K.
Venue
Nature Reviews Clinical Oncology
Published
2022-11-28
Volume
20
Issue
2
Pages
69-82
ISSN
  • 1759-4774 (ISSN-L)
  • 1759-4782
OpenAlex
W4310117627
Cited by
230
References
19
FWCI
10.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Criteria for the translation of radiomics into clinically useful tests. https://app.cochat.ai/papers/10.1038/s41571-022-00707-0
The paper
Huang, E. P., O’Connor, J. P. B., McShane, L. M., Giger, M. L., Lambin, P., Kinahan, P. E., Siegel, E. L., & Shankar, L. K. (2023). Criteria for the translation of radiomics into clinically useful tests. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-022-00707-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.